Vitreous mediators in retinal hypoxic diseases

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Dell'Omo, Roberto ^a   Semeraro, Francesco ^b   Bamonte, Giulio ^c   Cifariello, Francesco ^a   Romano, Mario R ^a   Costagliola, Ciro ^a  

^a UNIVERSITY OF MOLISE   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c HAGA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CONNECTIVE TISSUE GROWTH FACTOR; CYCLOOXYGENASE 2; CYTOKINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FRACTALKINE; GAMMA INTERFERON; GLUTAMIC ACID; GROWTH FACTOR; HIGH MOBILITY GROUP B1 PROTEIN; HYPOXIA INDUCIBLE FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PROSTAGLANDIN E2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SOMATOMEDIN C; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; BLOOD RETINA BARRIER; CALCIUM TRANSPORT; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; COLORIMETRY; DIABETIC RETINOPATHY; DNA HYBRIDIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXCITOTOXICITY; FLOW CYTOMETRY; HUMAN; HYPOXIA; IMMUNE RESPONSE; INFLAMMATION; LIPID PEROXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETINA DISEASE; RETINA HYPOXIA; REVIEW; TISSUE REPAIR; VITREOUS BODY; VITREOUS HEMORRHAGE; ANIMAL; ANOXIA; METABOLISM; PATHOLOGY; RETINA;

ANIMALS; ANOXIA; CHEMOKINES; CYTOKINES; HUMANS; OXIDATIVE STRESS; RETINA;

EID: 84873332727     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/935301     Document Type: Review

References (226)

1. Janáky M., Grósz A., Tóth E., Benedek K., Benedek G., Hypobaric hypoxia reduces the amplitude of oscillatory potentials in the human ERG. Documenta Ophthalmologica 2007 114 1 45 51 10.1007/s10633-006-9038-5 (Pubitemid 46206515)
2. Tinjust D., Kergoat H., Lovasik J. V., Neuroretinal function during mild systemic hypoxia. Aviation Space and Environmental Medicine 2002 73 12 1189 1194 2-s2.0-0036896060 (Pubitemid 35429616)
3. Brown G. C., Magargal L. E., The ocular ischemic syndrome. Clinical, fluorescein angiographic and carotid angiographic features. International Ophthalmology 1988 11 4 239 251 2-s2.0-0023711188
4. Purtscher O., Angiopathia retinae traumatica: lymphorrhagien desaugengrundes. Graefe's Archive for Clinical and Experimental Ophthalmology 1912 82 347 371 10.1007/BF01929449
5. Buckley S. A., James B., Purtscher's retinopathy. Postgraduate Medical Journal 1996 72 749 409 412 10.1136/pgmj.72.849.409 (Pubitemid 26237380)
6. Kitagawa K., Matsumoto M M., Tagaya M., Ischemic tolerance'phenomenon found in the brain. Brain Research 1990 528 1 21 24 10.1016/0006-8993(90)90189-I (Pubitemid 20292932)
7. Prass K., Scharff A., Ruscher K., Löwl D., Muselmann C., Victorov I., Kapinya K., Dirnagl U., Meisel A., Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin. Stroke 2003 34 8 1981 1986 2-s2.0-0042122371 10.1161/01.STR.0000080381.76409.B2 (Pubitemid 36944794)
8. Vilcek J., Feldmann M., Historical review: cytokines as therapeutics and targets of therapeutics. Trends in Pharmacological Sciences 2004 25 4 201 209 10.1016/j.tips.2004.02.011 (Pubitemid 38519911)
9. Struyf S., Proost P., van Damme J., Regulation of the immune response by the interaction of chemokines and proteases. Advances in Immunology 2003 81 1 44 2-s2.0-0142254121 10.1016/S0065-2776(03)81001-5 (Pubitemid 38009040)
10. Aiello L. P., Avery R. L., Arrigg P. G., Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. The New England Journal of Medicine 1994 331 22 1480 1487 10.1056/NEJM199412013312203 (Pubitemid 24356306)
11. Vignali D. A., Multiplexed particle-based flow cytometric assays. Journal of Immunological Methods 2000 243 1-2 243 255 10.1016/S0022-1759(00)00238-6
12. Banerjee S., Savant V., Scott R. A. H., Curnow S. J., Wallace G. R., Murray P. L., Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders. Investigative Ophthalmology and Visual Science 2007 48 5 2203 2207 2-s2.0-34250160902 10.1167/iovs.06-1358 (Pubitemid 351261295)
13. Maier R., Weger M., Haller-Schober E. M., El-Shabrawi Y., Wedrich A., Theisl A., Aigner R., Barth A., Haas A., Multiplex bead analysis of vitreous and serum concentrations of inflammatory and proangiogenic factors in diabetic patients. Molecular Vision 2008 14 637 643 2-s2.0-41749085758 (Pubitemid 351486723)
14. Yoshimura T., Sonoda K. H., Sugahara M., Mochizuki Y., Enaida H., Oshima Y., Ueno A., Hata Y., Yoshida H., Ishibashi T., Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS ONE 2009 4 12 2-s2.0-77949537099 10.1371/journal.pone.0008158 e8158
15. Szabo M. E., Droy-Lefaix M. T., Doly M., Carre C., Braquet P., Ischemia and reperfusion-induced histologic changes in the rat retina: demonstration of a free radical-mediated mechanism. Investigative Ophthalmology and Visual Science 1991 32 5 1471 1478 2-s2.0-0025870118
16. Szabo M. E., Droy-Lefaix M. T., Doly M., Direct measurement of free radicals in ischemic/reperfused diabetic rat retina. Clinical Neuroscience 1997 4 5 240 245 2-s2.0-0030881922 (Pubitemid 27382877)
17. Kim S. Y., Kwak J. S., Shin J. P., Lee S. H., The protection of the retina from ischemic injury by the free radical scavenger EGb 761 and zinc in the cat retina. Ophthalmologica 1998 212 4 268 274 2-s2.0-0031775622 10.1159/000027305 (Pubitemid 28293622)
18. Hirose F., Kiryu J., Miyamoto K., Nishijima K., Miyahara S., Katsuta H., Tamura H., Honda Y., In vivo evaluation of retinal injury after transient ischemia in hypertensive rats. Hypertension 2004 43 5 1098 1102 2-s2.0-2342452652 10.1161/01.HYP.0000123069.02156.8a (Pubitemid 38579920)
19. Kowluru R. A., Kowluru V., Xiong Y., Ho Y. S., Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress. Free Radical Biology and Medicine 2006 41 8 1191 1196 2-s2.0-33749070956 10.1016/j.freeradbiomed.2006.01.012 (Pubitemid 44466317)
20. Chen B. H., Caballero S., Seo S., Grant M. B., Lewin A. S., Delivery of antioxidant enzyme genes to protect against ischemia/reperfusion-induced injury to retinal microvasculature. Investigative Ophthalmology and Visual Science 2009 50 12 5587 5595 2-s2.0-73349128447 10.1167/iovs.09-3633
21. Dong A., Shen J., Krause M., Akiyama H., Hackett S. F., Lai H., Campochiaro P. A., Superoxide dismutase 1 protects retinal cells from oxidative damage. Journal of Cellular Physiology 2006 208 3 516 526 10.1002/jcp.20683 (Pubitemid 44141876)
22. Nayak M. S., Kita M., Marmor M. F., Protection of rabbit retina from ischemic injury by superoxide dismutase and catalase. Investigative Ophthalmology and Visual Science 1993 34 6 2018 2022 2-s2.0-0027157123 (Pubitemid 23148638)
23. Esterbauer H., Schaur R. J., Zollner H., Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biology and Medicine 1991 11 1 81 128 2-s2.0-0025814980 10.1016/0891-5849(91)90192-6 (Pubitemid 121003917)
24. Poli G., Schaur R. J., 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life 2000 50 4-5 315 321 2-s2.0-0034456018 10.1080/15216540051081092 (Pubitemid 32289090)
25. Kaur C., Sivakumar V., Foulds W. S., Early response of neurons and glial cells to hypoxia in the retina. Investigative Ophthalmology and Visual Science 2006 47 3 1126 1141 10.1167/iovs.05-0518 (Pubitemid 46768349)
26. Kashiwagi K., Iizuka Y., Mochizuki S., Tsumamoto Y., Mishima H. K., Araie M., Suzuki Y., Tsukahara S., Differences in nitric oxide production: a comparison of retinal ganglion cells and retinal glial cells cultured under hypoxic conditions. Molecular Brain Research 2003 112 1-2 126 134 2-s2.0-0037430883 10.1016/S0169-328X(03)00058-5 (Pubitemid 36369254)
27. Iadecola C., Bright and dark sides of nitric oxide in ischemic brain injury. Trends in Neurosciences 1997 20 3 132 139 2-s2.0-0031020172 10.1016/S0166-2236(96)10074-6 (Pubitemid 27086729)
28. Toda N., Nakanishi-Toda M., Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy. Progress in Retinal and Eye Research 2007 26 3 205 238 2-s2.0-33947703167 10.1016/j.preteyeres.2007.01.004 (Pubitemid 46498800)
29. Bolaños J. P., Almeida A., Roles of nitric oxide in brain hypoxia ischemia. Biochimica et Biophysica Acta 1999 1411 2-3 415 436 10.1016/S0005-2728(99)00030-4 (Pubitemid 29221965)
30. Fukumura D., Gohongi T., Kadambi A., Izumi Y., Ang J., Yun C. O., Buerk D. G., Huang P. L., Jain R. K., Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proceedings of the National Academy of Sciences of the United States of America 2001 98 5 2604 2609 2-s2.0-0035956947 10.1073/pnas.041359198 (Pubitemid 32209529)
31. Mishra O. P., Zubrow A. B., Ashraf Q. M., Nitric oxide-mediated activation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) during hypoxia in cerebral cortical nuclei of newborn piglets. Neuroscience 2004 123 1 179 186 2-s2.0-0345118105 10.1016/j.neuroscience.2003. 08.008 (Pubitemid 37518485)
32. 2+/calmodulin-dependent protein kinase IV activity during hypoxia in neuronal nuclei from newborn piglets. Neuroscience Letters 2002 335 1 5 8 2-s2.0-0037137506 10.1016/S0304-3940(02) 01138-2 (Pubitemid 35379802)
33. Zubrow A. B., Delivoria-Papadopoulos M., Ashraf Q. M., Ballesteros J. R., Fritz K. I., Mishra O. P., Nitric oxide-mediated expression of Bax protein and DNA fragmentation during hypoxia in neuronal nuclei from newborn piglets. Brain Research 2002 954 1 60 67 2-s2.0-0036838504 10.1016/S0006-8993(02)03342-5 (Pubitemid 35223441)
34. Nguyen T., Brunson D., Crespi C. L., Penman B. W., Wishnok J. S., Tannenbaum S. R., DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proceedings of the National Academy of Sciences of the United States of America 1992 89 7 3030 3034 2-s2.0-0026522884
35. Zhang R. L., Chopp M., Chen H., Garcia J. H., Temporal profile of ischemic tissue damage, neutrophil response, and vascular plugging following permanent and transient (2H) middle cerebral artery occlusion in the rat. Journal of the Neurological Sciences 1994 125 1 3 10 2-s2.0-0028102479 10.1016/0022-510X(94)90234-8 (Pubitemid 24240180)
36. Gross W. L., Bak M. I., Ingwall J. S., Arstall M. A., Smith T. W., Balligand J. L., Kelly R. A., Nitric oxide inhibits creatinekinase and regulates rat heart contractile reserves. Proceedings of the National Academy of Sciences of the United States of America 1996 93 11 5604 5609 10.1073/pnas.93.11.5604 (Pubitemid 26159498)
37. Beckman J. S., Beckman T. W., Chen J., Marshall P. A., Freeman B. A., Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proceedings of the National Academy of Sciences of the United States of America 1990 87 4 1620 1624 2-s2.0-0025189864
38. Lipton S. A., Choi Y. B., Pan Z. H., Lei S. Z., Chen H. S. V., Sucher N. J., Loscalzo J., Singel D. J., Stamler J. S., A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993 364 6438 626 632 2-s2.0-0027194540 10.1038/364626a0 (Pubitemid 23274719)
39. Marumo T., Noll T., Schini-Kerth V. B., Harley E. A., Duhault J., Piper H. M., Busse R., Significance of nitric oxide and peroxynitrite in permeability changes of the retinal microvascular endothelial cell monolayer induced by vascular endothelial growth factor. Journal of Vascular Research 1999 36 6 510 515 2-s2.0-0033373370 (Pubitemid 30020056)
40. Salgo M. G., Bermúdez E., Squadrito G. L., Pryor W. A., Peroxynitrite causes DNA damage and oxidation of thiols in rat thymocytes. Archives of Biochemistry and Biophysics 1995 322 2 500 505 10.1006/abbi.1995. 1493
41. Salvemini D., Wang Z., Stern M., Currie M. G., Misko T. P., Peroxynitrite decomposition catalysts: therapeutics for peroxynitrite-mediated pathology. Proceedings of the National Academy of Sciences of the United States of America 1998 95 5 2695 2703
42. Anderson S. M., Krinsky N. I., Protective action of carotenoid pigments against photodynamic damage to liposomes. Photochemistry and Photobiology 1973 18 5 403 408 10.1111/j.1751-1097.1973.tb06440.x
43. Arstila A. U., Smith M. A., Trump B. F., Microsomal lipid peroxidation: morphological characterization. Science 1972 175 4021 530 533 2-s2.0-0015493388
44. Kondo T., Kinouchi H., Kawase M., Yoshimoto T., Differential response in the release of hydrogen peroxide between astroglial cells and endothelial cells following hypoxia/reoxygenation. Neuroscience Letters 1996 215 2 103 106 2-s2.0-0030572716 10.1016/S0304-3940(96)12954-2 (Pubitemid 26313228)
45. Auge N., Pieraggi M. T., Thiers J. C., Negre-Salvayre A., Salvayre R., Proliferative and cytotoxic effects of mildly oxidized low-density lipoproteins on vascular smooth-muscle cells. Biochemical Journal 1995 309 3 1015 1020 2-s2.0-0029150698
46. D'Amore P. A., Sweet E., Effects of hyperoxia on microvascular cells in vitro. In Vitro Cellular and Developmental Biology 1987 23 2 123 128 10.1007/BF02623592
47. Halks-Miller M., Henderson M., Eng L. F., α tocopherol decreases lipid peroxidation, neuronal necrosis, and reactive gliosis in reaggregate cultures of fetal rat brain. Journal of Neuropathology and Experimental Neurology 1986 45 4 471 484 2-s2.0-0022547408 (Pubitemid 16059852)
48. 2 and genistein differentially modulate protein tyrosine phosphorylation, endothelial morphology, and monolayer barrier function. Biochemical and Biophysical Research Communications 1998 249 2 461 466 2-s2.0-0032547153 10.1006/bbrc.1998.9172 (Pubitemid 28431776)
49. Du Y., Miller C. M., Kern T. S., Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radical Biology and Medicine 2003 35 11 1491 1499 2-s2.0-0344012015 10.1016/j.freeradbiomed.2003.08.018 (Pubitemid 37452474)
50. Kowluru R. A., Diabetic retinopathy: mitochondrial dysfunction and retinal capillary cell death. Antioxidants and Redox Signaling 2005 7 11-12 1581 1587 2-s2.0-28844466951 10.1089/ars.2005.7.1581 (Pubitemid 41767993)
51. Nishikawa T., Araki E., Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxidants and Redox Signaling 2007 9 3 343 353 2-s2.0-33846407051 10.1089/ars.2006.1458 (Pubitemid 46150966)
52. Kowluru R. A., Effect of advanced glycation end products on accelerated apoptosis of retinal capillary cells under in vitro conditions. Life Sciences 2005 76 9 1051 1060 2-s2.0-10444246524 10.1016/j.lfs.2004.10.017 (Pubitemid 39643404)
53. Grammas P., Riden M., Retinal endothelial cells are more susceptible to oxidative stress and increased permeability than brain-derived endothelial cells. Microvascular Research 2003 65 1 18 23 2-s2.0-0037289250 10.1016/S0026-2862(02)00016-X (Pubitemid 36263286)
54. Du Y., Smith M. A., Miller C. M., Kern T. S., Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. Journal of Neurochemistry 2002 80 5 771 779 10.1046/j.0022-3042.2001.00737.x (Pubitemid 34809229)
55. Castilho Á., Aveleira C. A., Leal E. C., Simões N. F., Fernandes C. R., Meirinhos R. I., Baptista F. I., Ambrósio A. F., Heme oxygenase-1 protects retinal endothelial cells against high glucose- and oxidative/nitrosative stress-induced toxicity. PLoS ONE 2012 7 8 e42428 10.1371/journal.pone.0042428
56. Massey S. C., Cell types using glutamate as a neurotransmitter in the vertebrate retina. Progress in Retinal and Eye Research 1990 9 399 425 10.1016/0278-4327(90)90013-8 (Pubitemid 20096528)
57. Benveniste H., Drejer J., Schousboe A., Diemer N. H., Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. Journal of Neurochemistry 1984 43 5 1369 1374 2-s2.0-0021707433 (Pubitemid 15205893)
58. Lu Y. M., Lu B. F., Zhao F. Q., Yan Y. L., Ho X. P., Accumulation of glutamate is regulated by calcium and protein kinase C in rat hippocampal slices exposed to ischemic states. Hippocampus 1993 3 2 221 227 2-s2.0-0027174733 (Pubitemid 23130077)
59. Brandstätter J. H., Koulen P., Wässle H., Diversity of glutamate receptors in the mammalian retina. Vision Research 1998 38 10 1385 1397 10.1016/S0042-6989(97)00176-4 (Pubitemid 28239261)
60. Gründer T., Kohler K., Guenthe E., Alterations in NMDA receptor expression during retinal degeneration in the RCS rat. Visual Neuroscience 2001 18 5 781 787 10.1017/S0952523801185111 (Pubitemid 34267195)
61. Sucher N. J., Lipton S. A., Dreyer E. B., Molecular basis of glutamate toxicity in retinal ganglion cells. Vision Research 1997 37 24 3483 3493 2-s2.0-0030728050 10.1016/S0042-6989(97)00047-3 (Pubitemid 27491629)
62. MacDermott A. B., Mayer M. L., Westbrook G. L., NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones. Nature 1986 321 6069 519 522 2-s2.0-0022479032 (Pubitemid 16052255)
63. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 1991 252 5007 851 853 2-s2.0-0025923461 (Pubitemid 121000528)
64. 2+-permeable non-NMDA glutamate receptors during the period of histogenetic cell death. Neuroscience Letters 1993 153 1 32 36 2-s2.0-0027207180 10.1016/0304-3940(93)90070-2 (Pubitemid 23147030)
65. Siliprandi R., Canella R., Carmignoto G., Schiavo N., Zanellato A., Zanoni R., Vantini G., N-methyl-D-aspartate-induced neurotoxicity in the adult rat retina. Visual Neuroscience 1992 8 6 567 573 2-s2.0-0026873352
66. Sucher N. J., Aizenman E., Lipton S. A., N-methyl-D-aspartate antagonists prevent kainate neurotoxicity in rat retinal ganglion cells in vitro. Journal of Neuroscience 1991 11 4 966 971 2-s2.0-0025942891
67. 2+ flux in mammalian central neurons. NeuroReport 1990 1 1 29 32 2-s2.0-0025671825
68. Nicotera P., Orrenius S., The role of calcium in apoptosis. Cell Calcium 1998 23 2-3 173 180 2-s2.0-0031977191 10.1016/S0143-4160(98)90116-6 (Pubitemid 28188002)
69. Sattler R., Tymianski M., Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Molecular Neurobiology 2001 24 1-3 107 129 10.1385/MN:24:1-3:107 (Pubitemid 34066681)
70. Dugan L. L., Sensi S. L., Canzoniero L. M. T., Handran S. D., Rothman S. M., Lin T. S., Goldberg M. P., Choi D. W., Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. Journal of Neuroscience 1995 15 10 6377 6388 2-s2.0-0028882764
71. Katsura K., Kristian T., Siesjo B. K., Energy metabolism, ion homeostasis, and cell damage in the brain. Biochemical Society Transactions 1994 22 4 991 996 (Pubitemid 24373205)
72. Garthwaite G., Garthwaite J., AMPA neurotoxicity in rat cerebellar and hippocampal slices: histological evidence for three mechanisms. European Journal of Neuroscience 1991 3 8 715 728 2-s2.0-0025895544
73. Kiss J. P., Vizi E. S., Nitric oxide: a novel link between synaptic and nonsynaptic transmission. Trends in Neurosciences 2001 24 4 211 215 2-s2.0-0035313948 10.1016/S0166-2236(00)01745-8 (Pubitemid 32204376)
74. De A., Krueger J. M., Simasko S. M., Glutamate induces the expression and release of tumor necrosis factor- α in cultured hypothalamic cells. Brain Research 2005 1053 1-2 54 61 2-s2.0-23644454963 10.1016/j.brainres.2005.06.044 (Pubitemid 41116790)
75. Noda M., Nakanishi H., Nabekura J., Akaike N., AMPA-kainate subtypes of glutamate receptor in rat cerebral microglia. Journal of Neuroscience 2000 20 1 251 258 2-s2.0-0034001914 (Pubitemid 30220512)
76. Matute C., Alberdi E., Domercq M., Pérez-Cerdá F., Pérez-Samartín A., Sánchez-Gómez M. V., The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends in Neurosciences 2001 24 224 230 10.1016/S0166-2236(00)01746-X (Pubitemid 32204379)
77. Hagan P., Poole S., Bristow A. F., Tilders F., Silverstein F. S., Intracerebral NMDA injection stimulates production of interleukin-1 β in perinatal rat brain. Journal of Neurochemistry 1996 67 5 2215 2218 2-s2.0-0029840954 (Pubitemid 26349703)
78. Ratan R. R., Murphy T. H., Baraban J. M., Oxidative stress induces apoptosis in embryonic cortical neurons. Journal of Neurochemistry 1994 62 1 376 379 2-s2.0-0028095981
79. Meister A., Anderson M. E., Glutathione. Annual Review of Biochemistry 1983 52 711 760 10.1146/annurev.bi.52.070183.003431 (Pubitemid 13030692)
80. Mizui T., Kinouchi H., Chan P. H., Depletion of brain glutathione by buthionine sulfoximine enhances cerebral ischemic injury in rats. American Journal of Physiology 1992 262 2 H313 H317 2-s2.0-0026555334
81. Bobyn P. J., Franklin J. L., Wall C. M., Thornhill J. A., Juurlink B. H. J., Paterson P. G., The effects of dietary sulfur amino acid deficiency on rat brain glutathione concentration and neural damage in global hemispheric hypoxia-ischemia. Nutritional Neuroscience 2002 5 6 407 416 2-s2.0-0036903106 10.1080/1028415021000055952 (Pubitemid 35469540)
82. Coyle J. T., Puttfarcken P., Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993 262 5134 689 695 2-s2.0-0027686249 (Pubitemid 23350687)
83. Harada T., Harada C., Nakamura K., The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. Journal of Clinical Investigation 2007 117 7 1763 1770 10.1172/JCI30178 (Pubitemid 47036310)
84. Yoshida S., Yoshida A., Ishibashi T., Induction of IL-8, MPC-1, and bFGF by TNF- α in retinal glial cells: implications for retinal neovascularization during post-ischemic inflammation. Graefe's Archive for Clinical and Experimental Ophthalmology 2004 242 5 409 413 2-s2.0-3042538729 10.1007/s00417-004-0874-2 (Pubitemid 38801529)
85. Zheng L., Gong B., Hatala D. A., Kern T. S., Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes. Investigative Ophthalmology and Visual Science 2007 48 1 361 367 10.1167/iovs.06-0510 (Pubitemid 47251425)
86. Joussen A. M., Poulaki V., Qin W., Kirchhof B., Mitsiades N., Wiegand S. J., Rudge J., Yancopoulos G. D., Adamis A. P., Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. American Journal of Pathology 2002 160 2 501 509 2-s2.0-0036174019 (Pubitemid 34160327)
87. Wong D., Dorovini-Zis K., Upregulation of intercellular adhesion molecule-1 (ICAM-1) expression in primary cultures of human brain microvessel endothelial cells by cytokines and lipopolysaccharide. Journal of Neuroimmunology 1992 39 1-2 11 22 2-s2.0-0026650384 10.1016/0165-5728(92)90170-P
88. Hess D. C., Bhutwala T., Sheppard J. C., Zhao W., Smith J., ICAM-1 expression on human brain microvascular endothelial cells. Neuroscience Letters 1994 168 1-2 201 204 2-s2.0-0028353728 10.1016/0304-3940(94)90450-2 (Pubitemid 24097357)
89. McHale J. F., Harari O. A., Marshall D., Haskard D. O., TNF- α and IL-1 sequentially induce endothelial ICAM-1 and VCAM-1 expression in MRL/lpr lupus-prone mice. Journal of Immunology 1999 163 7 3993 4000 2-s2.0-0033214841 (Pubitemid 29450929)
90. Feuerstein G., Wang X., Barone F. C., Cytokines in brain ischemia-the role of TNF- α Cellular and Molecular Neurobiology 1998 18 6 695 701 10.1023/A:1020226020062 (Pubitemid 29012946)
91. Wang J., Beekhuizen H., van Furth R., Surface molecules involved in the adherence of recombinant interferon- γ (rIFN- γ)-stimulated human monocytes to vascular endothelial cells. Clinical and Experimental Immunology 1994 95 2 263 269 2-s2.0-0028363229 (Pubitemid 24207137)
92. López-Figueroa M. O., Day H. E., Lee S., Rivier C., Akil H., Watson S. J., Temporal and anatomical distribution of nitric oxide synthase mRNA expression and nitric oxide production during central nervous system infl ammation. Brain Research 2000 852 1 239 246 10.1016/S0006-8993(99)02241-6 (Pubitemid 30017759)
93. Kadhim H., Khalifa M., Deltenre P., Casimir G., Sébire G., Molecular mechanisms of cell death in periventricular leukomalacia. Neurology 2006 67 2 293 299 2-s2.0-33747036449 10.1212/01.wnl.0000224754.63593.c4
94. Kern T. S., Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Experimental Diabetes Research 2007 2007 14 95103 2-s2.0-41149099068 10.1155/2007/95103
95. Iliaki E., Poulaki V., Mitsiades N., Mitsiades C. S., Miller J. W., Gragoudas E. S., Role of α 4 integrin (cd49d) in the pathogenesis of diabetic retinopathy. Investigative Ophthalmology and Visual Science 2009 50 10 4890 4904
96. Adamis A. P., Berman A. J., Immunological mechanisms in the pathogenesis of diabetic retinopathy. Seminars in Immunopathology 2008 30 2 65 84 10.1007/s00281-008-0111-x
97. Tawfik A., Sanders T., Kahook K., Akeel S., Elmarakby A., Al-Shabrawey M., Suppression of retinal peroxisome proliferator-activated receptor γ in experimental diabetes and oxygen-induced retinopathy: role of NADPH oxidase. Investigative Ophthalmology and Visual Science 2009 50 2 878 884 2-s2.0-59449102868 10.1167/iovs.08-2005
98. Tezel G., Wax M. B., Increased production of tumor necrosis factor- α by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. Journal of Neuroscience 2000 20 23 8693 8700 2-s2.0-0034548875
99. Carswell E. A., Old L. J., Kassel R. L., Green S., Fiore N., Williamson B., An endotoxin-induced serum factor that causes necrosis of tumors. Proceedings of the National Academy of Sciences of the United States of America 1975 72 9 3666 3670 10.1073/pnas.72.9.3666
100. Fràter-Schröder M., Risau W., Hallmann R., Gautschi P., Böhlen P., Tumor necrosis factor type α a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proceedings of the National Academy of Sciences of the United States of America 1987 84 15 5277 5281 10.1073/pnas.84.15.5277
101. Rosenbaum J. T., Howes E. L. J., Rubin R. M., Samples J. R., Ocular inflammatory effects of intravitreally injected tumor necrosis factor. American Journal of Pathology 1988 133 1 47 53
102. Yoshida S., Ono M., Shono T., Izumi H., Ishibashi T., Suzuki H., Kuwano M., Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor α -dependent angiogenesis. Molecular and Cellular Biology 1997 17 7 4015 4023 2-s2.0-0031009807 (Pubitemid 27281877)
103. Giraudo E., Primo L., Audero E., Gerber H. P., Koolwijk P., Soker S., Klagsbrun M., Ferrara N., Bussolino F., Tumor necrosis factor- α regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells. The Journal of Biological Chemistry 1998 273 34 22128 22135 2-s2.0-0032555509 10.1074/jbc.273.34.22128 (Pubitemid 28405397)
104. Fajardo L. F., Kwan H. H., Kowalski J., Prionas S. D., Allison A. C., Dual role of tumor necrosis factor- α in angiogenesis. American Journal of Pathology 1992 140 3 539 544
105. Tartaglia L. A., Ayres T. M., Wong G. H. W., Goeddel D. V., A novel domain within the 55 kd TNF receptor signals cell death. Cell 1993 74 5 845 853 2-s2.0-0027275490 10.1016/0092-8674(93)90464-2 (Pubitemid 23270604)
106. Song H. Y., Régnier C. H., Kirschning C. J., Goeddel D. V., Rothe M., Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor- B and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proceedings of the National Academy of Sciences of the United States of America 1997 94 18 9792 9796 2-s2.0-12644272789 10.1073/pnas.94.18.9792 (Pubitemid 27408143)
107. Ishida S., Usui T., Yamashiro K., VEGF 164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization. Journal of Experimental Medicine 2003 198 3 483 489 10.1084/jem.20022027 (Pubitemid 36976059)
108. Lang R. A., Bishop M. J., Macrophages are required for cell death and tissue remodeling in the developing mouse eye. Cell 1993 74 3 453 462 10.1016/0092-8674(93)80047-I (Pubitemid 23244611)
109. Armstrong D., Ueda T., Ueda T., Aljada A., Browne R., Fukuda S., Spengler R., Chou R., Hartnett M., Buch P., Dandona P., Sasisekharan R., Dorey C. K., Lipid hydroperoxide stimulates retinal neovascularization in rabbit retina through expression of tumor necrosis factor- α vascular endothelial growth factor and platelet-derived growth factor. Angiogenesis 1998 2 1 93 104 2-s2.0-0002499659 (Pubitemid 128511976)
110. Camussi G., Albano E., Tetta C., Bussolino F., The molecular action of tumor necrosis factor- α European Journal of Biochemistry 1991 202 1 3 14 2-s2.0-0026077170
111. Majka S., McGuire P. G., Das A., Regulation of matrix metalloproteinase expression by tumor necrosis factor in a murine model of retinal neovascularization. Investigative Ophthalmology and Visual Science 2002 43 1 260 266 2-s2.0-0036139719 (Pubitemid 34032468)
112. Derevjanik N. L., Vinores S. A., Xiao W. H., Mori K., Turon T., Hudish T., Dong S., Campochiaro P. A., Quantitative assessment of the integrity of the blood-retinal barrier in mice. Investigative Ophthalmology and Visual Science 2002 43 7 2462 2467 2-s2.0-0036295180 (Pubitemid 34700682)
113. Wilkinson-Berka J. L., Tan G., Jaworski K., Miller A. G., Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology. Circulation Research 2009 104 1 124 133 2-s2.0-59649118170 10.1161/CIRCRESAHA.108.176008
114. Zeng H. Y., Green W. R., Tso M. O. M., Microglial activation in human diabetic retinopathy. Archives of Ophthalmology 2008 126 2 227 232 2-s2.0-39049127031 10.1001/archophthalmol.2007.65 (Pubitemid 351240852)
115. Joussen A. M., Poulaki V., Mitsiades N., Kirchhof B., Koizumi K., Döhmen S., Adamis A. P., Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF- α suppression. The FASEB Journal 2002 16 3 438 440 2-s2.0-0036517850
116. Demircan N., Safran B. G., Soylu M., Ozcan A. A., Sizmaz S., Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye 2006 20 12 1366 1369 2-s2.0-33845546564 10.1038/sj.eye.6702138 (Pubitemid 44921137)
117. Funatsu H., Yamashita H., Noma H., Mimura T., Nakamura S., Sakata K., Hori S., Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Graefe's Archive for Clinical and Experimental Ophthalmology 2005 243 1 3 8 2-s2.0-12444278290 10.1007/s00417-004-0950-7
118. Malik R. A., Li C., Aziz W., Olson J. A., Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy. Journal of Cellular and Molecular Medicine 2005 9 3 692 697 (Pubitemid 44151956)
119. Murugeswari P., Shukla D., Rajendran A., Kim R., Namperumalsamy P., Muthukkaruppan V., Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease. Retina 2008 28 6 817 824 2-s2.0-47749107263 10.1097/IAE. 0b013e31816576d5
120. Hiasa K. I., Ishibashi M., Ohtani K., Inoue S., Zhao Q., Kitamoto S., Sata M., Ichiki T., Takeshita A., Egashira K., Gene transfer of stromal cell-derived factor-1 α enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation 2004 109 20 2454 2461 2-s2.0-2542464782 10.1161/01.CIR.0000128213. 96779.61 (Pubitemid 38679567)
121. Arjamaa O., Pöllönen M., Kinnunen K., Ryhänen T., Kaarniranta K., Increased IL-6 levels are not related to NF- B or HIF-1 α transcription factors activity in the vitreous of proliferative diabetic retinopathy. Journal of Diabetes and Its Complications 2011 25 6 393 397 10.1016/j.jdiacomp.2011.06.002
122. Goodwin G. H., Sanders C., Johns E. W., A new group of chromatin associated proteins with a high content of acidic and basic amino acids. European Journal of Biochemistry 1973 38 1 14 19 2-s2.0-0015857760
123. Lotze M. T., Tracey K. J., High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nature Reviews Immunology 2005 5 4 331 342 2-s2.0-17144376810 10.1038/nri1594 (Pubitemid 40516158)
124. Arimura N., Ki-I Y., Hashiguchi T., Kawahara K. I., Biswas K. K., Nakamura M., Sonoda Y., Yamakiri K., Okubo A., Sakamoto T., Maruyama I., Intraocular expression and release of high-mobility group box 1 protein in retinal detachment. Laboratory Investigation 2009 89 3 278 289 2-s2.0-61349194969 10.1038/labinvest.2008.165
125. Watanabe T., Keino H., Sato Y., Kudo A., Kawakami H., Okada A. A., High mobility group box protein-1 in experimental autoimmune uveoretinitis. Investigative Ophthalmology and Visual Science 2009 50 5 2283 2290 10.1167/iovs.08-2709
126. Hori O., Brett J., Slattery T., Cao R., Zhang J., Jing Xian Chen, Nagashima M., Lundh E. R., Vijay S., Nitecki D., Morser J., Stern D., Schmidt A. M., The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. The Journal of Biological Chemistry 1995 270 43 25752 25761 2-s2.0-0028851635 10.1074/jbc.270.43.25752
127. Jakuš V., Rietbrock N., Advanced glycation end-products and the progress of diabetic vascular complications. Physiological Research 2004 53 2 131 142 2-s2.0-1942438654 (Pubitemid 38525116)
128. Yang S., Hirooka K., Liu Y., Fujita T., Fukuda K., Nakamutra T., Itano T., Zhang J., Nishibori M., Shiraga F., Deleterious role of anti-high mobility group box 1 monoclonal antibody in retinal ischemia-reperfusion injury. Current Eye Research 2011 36 11 1037 1046 10.3109/02713683.2011.594201
129. Klune J. R., Dhupar R., Cardinal J., Billiar T. R., Tsung A., HMGB1: endogenous danger signaling. Molecular Medicine 2008 14 7-8 476 484 2-s2.0-48149096398 10.2119/2008-00034.Klune
130. Hreggvidsdottir H. S., Östberg T., Wähämaa H., Schierbeck H., Aveberger A. C., Klevenvall L., Palmblad K., Ottosson L., Andersson U., Harris H. E., The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. Journal of Leukocyte Biology 2009 86 3 655 662 2-s2.0-70149098507 10.1189/jlb.0908548
131. Mitola S., Belleri M., Urbinati C., Coltrini D., Sparatore B., Pedrazzi M., Melloni E., Presta M., Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. Journal of Immunology 2006 176 1 12 15 2-s2.0-29644441337 (Pubitemid 43023243)
132. Biscetti F., Straface G., de Cristofaro R., Lancellotti S., Rizzo P., Arena V., Stigliano E., Pecorini G., Egashira K., de Angelis G., Ghirlanda G., Flex A., High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism. Diabetes 2010 59 6 1496 1505 2-s2.0-77953185946 10.2337/db09-1507
133. Lee J. J., Hsiao C. C., Yang I., Chou M. H., Wu C. L., Wei Y. C., Chen C.-H., Chuang J. H., High-mobility group box 1 protein is implicated in advanced glycation end products-induced vascular endothelial growth factor a production in the rat retinal ganglion cell line RGC-5. Molecular Vision 2012 18 838 850
134. Murphy P. M., Baggiolini M., Charo I. F., Hebert C. A., Horuk R., Matsushima K., Miller L. H., Oppenheim J. J., Power C. A., International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacological Reviews 2000 52 1 145 176 2-s2.0-0034092634 (Pubitemid 30127598)
135. Abu El-Asrar A. M., Struyf S., Kangave D., Geboes K., van Damme J., Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. European Cytokine Network 2006 17 3 155 165 2-s2.0-39049193307
136. Hong K. H., Ryu J., Han K. H., Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A. Blood 2005 105 4 1405 1407 2-s2.0-13544266205 10.1182/blood-2004-08-3178 (Pubitemid 40223654)
137. Silverman M. D., Zamora D. O., Pan Y., Texeira P. V., Baek S. H., Planck S. R., Rosenbaum J. T., Constitutive and inflammatory mediator-regulated fractalkine expression in human ocular tissues and cultured cells. Investigative Ophthalmology and Visual Science 2003 44 4 1608 1615 2-s2.0-0037378884 10.1167/iovs.02-0233 (Pubitemid 36378588)
138. You J. J., Yang C. H., Huang J. S., Chen M. S., Yang C. M., Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis. Investigative Ophthalmology and Visual Science 2007 48 11 5290 5298 10.1167/iovs.07-0187 (Pubitemid 351260943)
139. Wakabayashi Y., Usui Y., Okunuki Y., Takeuchi M., Kezuka T., Iwasaki T., Goto H., Increased levels of monokine induced by interferon- γ (Mig) in the vitreous of patients with diabetic retinopathy. Diabetic Medicine 2008 25 7 875 877 2-s2.0-49649119508 10.1111/j.1464-5491.2008.02466.x
140. Joussen A. M., Poulaki V., Le M. L., Koizumi K., Esser C., Janicki H., Schraermeyer U., Kociok N., Fauser S., Kirchhof B., Kern T. S., Adamis A. P., A central role for inflammation in the pathogenesis of diabetic retinopathy. The FASEB Journal 2004 18 12 1450 1452 2-s2.0-7044228789 10.1096/fj.03-1476fje (Pubitemid 39561611)
141. Yamaguchi J. I., Kusano K. F., Masuo O., Kawamoto A., Silver M., Murasawa S., Bosch-Marce M., Masuda H., Losordo D. W., Isner J. M., Asahara T., Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003 107 9 1322 1328 2-s2.0-0037432293 10.1161/01.CIR.0000055313.77510.22 (Pubitemid 36314418)
142. de Falco E., Porcelli D., Torella A. R., Straino S., Iachininoto M. G., Orlandi A., Truffa S., Biglioli P., Napolitano M., Capogrossi M. C., Pesce M., SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 2004 104 12 3472 3482 2-s2.0-9444226473 10.1182/blood-2003-12-4423 (Pubitemid 39564415)
143. Walter D. H., Haendeler J., Reinhold J., Rochwalsky U., Seeger F., Honold J., Hoffmann J., Urbich C., Lehmann R., Arenzana-Seisdesdos F., Aicher A., Heeschen C., Fichtlscherer S., Zeiher A. M., Dimmeler S., Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circulation Research 2005 97 11 1142 1151 2-s2.0-33644663839 10.1161/01.RES.0000193596. 94936.2c
144. Reddy K., Zhou Z., Jia S. F., Lee T. H., Morales-Arias J., Cao Y., Kleinerman E. S., Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor. International Journal of Cancer 2008 123 4 831 837 2-s2.0-47049107160 10.1002/ijc.23582 (Pubitemid 352032409)
145. + cells to endothelial progenitor cells. Circulation 2008 117 2 206 215 2-s2.0-38049113170 10.1161/CIRCULATIONAHA.107.714691
146. Butler J. M., Guthrie S. M., Koc M., Afzal A., Caballero S., Brooks H. L., Mames R. N., Segal M. S., Grant M. B., Scott E. W., SDF-1 is both necessary and sufficient to promote proliferative retinopathy. Journal of Clinical Investigation 2005 115 1 86 93 2-s2.0-13744254861 10.1172/JCI200522869 (Pubitemid 40385508)
147. Blom I. E., Goldschmeding R., Leask A., Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy? Matrix Biology 2002 21 6 473 482 2-s2.0-0036775477 10.1016/S0945-053X(02)00055-0 (Pubitemid 35248272)
148. Abu El-Asrar A. M., Struyf S., Verbeke H., van Damme J., Geboes K., Circulating bone-marrow-derived endothelial precursor cells contribute to neovascularization in diabetic epiretinal membranes. Acta Ophthalmologica 2011 89 3 222 228 2-s2.0-79954986853 10.1111/j.1755-3768.2009.01700.x
149. Déry M. A. C., Michaud M. D., Richard D. E., Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. International Journal of Biochemistry and Cell Biology 2005 37 3 535 540 10.1016/j.biocel. 2004.08.012 (Pubitemid 40022930)
150. Mazure N. M., Brahimi-Horn M. C., Berta M. A., Benizri E., Bilton R. L., Dayan F., Ginouvès A., Berra E., Pouysségur J., HIF-1: master and commander of the hypoxic world: a pharmacological approach to its regulation by siRNAs. Biochemical Pharmacology 2004 68 6 971 980 2-s2.0-4143110440 10.1016/j.bcp.2004.04.022 (Pubitemid 39094259)
151. Pugh C. W., Ratcliffe P. J., Regulation of angiogenesis by hypoxia: role of the HIF system. Nature Medicine 2003 9 6 677 684 10.1038/nm0603-677 (Pubitemid 36749216)
152. Lukiw W. J., Ottlecz A., Lambrou G., Grueninger M., Finley J., Thompson H. W., Bazan N. G., Coordinate activation of HIF-1 and NF- B DNA binding and COX-2 and VEGF expression in retinal cells by hypoxia. Investigative Ophthalmology and Visual Science 2003 44 10 4163 4170 2-s2.0-0141765733 10.1167/iovs.02-0655 (Pubitemid 37186247)
153. Gao W., Ferguson G., Connell P., Walshe T., Murphy R., Birney Y. A., O'Brien C., Cahill P. A., High glucose concentrations alter hypoxia-induced control of vascular smooth muscle cell growth via a HIF-1 α -dependent pathway. Journal of Molecular and Cellular Cardiology 2007 42 3 609 619 2-s2.0-33847385903 10.1016/j.yjmcc.2006.12.006 (Pubitemid 46349124)
154. Treins C., Giorgetti-Peraldi S., Murdaca J., Monthouël-Kartmann M. N., van Obberghen E., Regulation of hypoxia-inducible factor (HIF)-1 activity and expression of HIF hydroxylases in response to insulin-like growth factor I. Molecular Endocrinology 2005 19 5 1304 1317 2-s2.0-17844364429 10.1210/me.2004-0239 (Pubitemid 40594126)
155. Poulaki V., Qin W., Joussen A. M., Hurlbut P., Wiegand S. J., Rudge J., Yancopoulos G. D., Adamis A. P., Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1 α and VEGF. Journal of Clinical Investigation 2002 109 6 805 815 2-s2.0-0036196081 10.1172/JCI200213776 (Pubitemid 34263157)
156. El-Asrar A. M. A., Missotten L., Geboes K., Expression of hypoxia-inducible factor-1 α and the protein products of its target genes in diabetic fibrovascular epiretinal membranes. British Journal of Ophthalmology 2007 91 6 822 826 2-s2.0-34249814615 10.1136/bjo.2006.109876 (Pubitemid 46846660)
157. Lim J. I., Spee C., Hinton D. R., A comparison of hypoxia-inducible factor- α in surgically excised neovascular membranes of patients with diabetes compared with idiopathic epiretinal membranes in nondiabetic patients. Retina 2010 30 9 1472 1478 2-s2.0-78049232810 10.1097/IAE.0b013e3181d6df09
158. Frede S., Stockmann C., Freitag P., Fandrey J., Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF- B. Biochemical Journal 2006 396 3 517 527 2-s2.0-33745003285 10.1042/BJ20051839 (Pubitemid 44228166)
159. Bonello S., Zähringer C., BelAiba R. S., Djordjevic T., Hess J., Michiels C., Kietzmann T., Görlach A., Reactive oxygen species activate the HIF-1 α promoter via a functional NF B site. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 4 755 761 2-s2.0-34247187576 10.1161/01.ATV.0000258979.92828.bc (Pubitemid 46606703)
160. Kinnunen K., Puustjärvi T., Teräsvirta M., Nurmenniemi P., Heikura T., Laidinen S., Paavonen T., Uusitalo H., Ylä-Herttuala S., Differences in retinal neovascular tissue and vitreous humour in patients with type 1 and type 2 diabetes. British Journal of Ophthalmology 2009 93 8 1109 1115 10.1136/bjo.2008.148841
161. Arjamaa O., Nikinmaa M., Salminen A., Kaarniranta K., Regulatory role of HIF-1 α in the pathogenesis of age-related macular degeneration (AMD). Ageing Research Reviews 2009 8 4 349 358 2-s2.0-69049088683 10.1016/j.arr.2009. 06.002
162. Salminen A., Kaarniranta K., Insulin/IGF-1 paradox of aging: regulation via AKT/IKK/NF- B signaling. Cellular Signalling 2010 22 4 573 577 2-s2.0-74449090245 10.1016/j.cellsig.2009.10.006
163. Ferrara N., Gerber H. P., LeCouter J., The biology of VEGF and its receptors. Nature Medicine 2003 9 6 669 676 2-s2.0-0037699954 10.1038/nm0603-669 (Pubitemid 36749215)
164. Takahashi H., Shibuya M., The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clinical Science 2005 109 3 227 241 2-s2.0-25144511910 10.1042/CS20040370 (Pubitemid 41337127)
165. Shibuya M., Ito N., Claesson-Welsh L., Structure and function of vascular endothelial growth factor receptor-1 and -2. Current Topics in Microbiology and Immunology 1999 237 60 83 (Pubitemid 128767694)
166. Campochiaro P. A., Ocular neovascularisation and excessive vascular permeability. Expert Opinion on Biological Therapy 2004 4 9 1395 1402 10.1517/14712598.4.9.1395 (Pubitemid 39222973)
167. Hiratsuka S., Kataoka Y., Nakao K., Nakamura K., Morikawa S., Tanaka S., Katsuki M., Maru Y., Shibuya M., Vascular endothelial growth factor A (VEGF-A) is involved in guidance of VEGF receptor-positive cells to the anterior portion of early embryos. Molecular and Cellular Biology 2005 25 1 355 363 2-s2.0-11144318701 10.1128/MCB.25.1.355-363.2005 (Pubitemid 40039825)
168. Sakurai Y., Ohgimoto K., Kataoka Y., Yoshida N., Shibuya M., Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice. Proceedings of the National Academy of Sciences of the United States of America 2005 102 4 1076 1081 2-s2.0-12844264070 10.1073/pnas.0404984102 (Pubitemid 40170728)
169. Asahara T., Bauters C., Pastore C., Kearney M., Rossow S., Bunting S., Ferrara N., Symes J. F., Isner J. M., Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 1995 91 11 2793 2801 2-s2.0-0029028527
170. Gennaro G., Ménard C., Michaud S. E., Rivard A., Age-dependent impairment of reendothelialization after arterial injury: role of vascular endothelial growth factor. Circulation 2003 107 2 230 233 2-s2.0-0037458068 10.1161/01.CIR.0000050652.47145.4C (Pubitemid 36135216)
171. Safran M., Kaelin W. G. Jr., HIF hydroxylation and the mammalian oxygen-sensing pathway. Journal of Clinical Investigation 2003 111 6 779 783 10.1172/JCI200318181 (Pubitemid 37074949)
172. Ikeda E., Achen M. G., Breier G., Risau W., Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. The Journal of Biological Chemistry 1995 270 34 19761 19766 2-s2.0-0029117223 10.1074/jbc.270.34.19761
173. Levy A. P., Levy N. S., Wegner S., Goldberg M. A., Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. The Journal of Biological Chemistry 1995 270 22 13333 13340 10.1074/jbc.270.22.13333
174. Stein I., Neeman M., Shweiki D., Itin A., Keshet E., Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Molecular and Cellular Biology 1995 15 10 5363 5368 2-s2.0-0029082384
175. Melder R. J., Koenig G. C., Witwer B. P., Safabakhsh N., Munn L. L., Jain R. K., During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nature Medicine 1996 2 9 992 997 2-s2.0-0029793371 10.1038/nm0996-992 (Pubitemid 26306837)
176. Lu P. C. S., Ye H., Maeda M., Azar D. T., Immunolocalization and gene expression of matrilysin during corneal wound healing. Investigative Ophthalmology and Visual Science 1999 40 1 20 27 (Pubitemid 29029567)
177. Min J. K., Kim Y. M., Kim S. W., Kwon M. C., Kong Y. Y., Hwang I. K., Won M. H., Rho J., Kwon Y. G., TNF-related activation-induced cytokine enhances leukocyte adhesiveness: induction of ICAM-1 and VCAM-1 via TNF receptor-associated factor and protein kinase C-dependent NF- B activation in endothelial cells. Journal of Immunology 2005 175 1 531 540 2-s2.0-21244499298 (Pubitemid 40884359)
178. Clermont A. C., Aiello L. P., Mori F., Aiello L. M., Bursell S. E., Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy. American Journal of Ophthalmology 1997 124 4 433 446 2-s2.0-0030770396 (Pubitemid 27425869)
179. Adamis A. P., Miller J. W., Bernal M. T., D'Amico D. J., Folkman J., Yeo T. K., Yeo K. T., Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. American Journal of Ophthalmology 1994 118 4 445 450 2-s2.0-0028123090 (Pubitemid 24307211)
180. Matsunaga N., Chikaraishi Y., Izuta H., Ogata N., Shimazawa M., Matsumura M., Hara H., Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy. Ophthalmology 2008 115 11 1916 1922 2-s2.0-54949090327 10.1016/j.ophtha.2008.06.025
181. Ozaki H., Seo M. S., Ozaki K., Yamada H., Yamada E., Okamoto N., Hofmann F., Wood J. M., Campochiaro P. A., Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. American Journal of Pathology 2000 156 2 697 707 2-s2.0-0033882794 (Pubitemid 30643824)
182. Kaur C., Sivakumar V., Foulds W. S., Early response of neurons and glial cells to hypoxia in the retina. Investigative Ophthalmology and Visual Science 2006 47 3 1125 1141 10.1167/iovs.05-0518 (Pubitemid 46768349)
183. Kaur C., Sivakumar V., Yong Z., Lu J., Foulds W. S., Ling E. A., Blood-retinal barrier disruption and ultrastructural changes in the hypoxic retina in adult rats: the beneficial effect of melatonin administration. Journal of Pathology 2007 212 4 429 439 2-s2.0-34547105066 10.1002/path.2195 (Pubitemid 47099020)
184. Penn J. S., Madan A., Caldwell R. B., Bartoli M., Caldwell R. W., Hartnett M. E., Vascular endothelial growth factor in eye disease. Progress in Retinal and Eye Research 2008 27 4 331 371 2-s2.0-48549088705 10.1016/j.preteyeres.2008.05.001
185. Kondo S., Kubota S., Shimo T., Nishida T., Yosimichi G., Eguchi T., Sugahara T., Takigawa M., Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases. Carcinogenesis 2002 23 5 769 776 2-s2.0-0036262188 (Pubitemid 34567515)
186. Pi L., Xia H., Liu J., Shenoy A. K., Hauswirth W. W., Scott E. W., Role of connective tissue growth factor in the retinal vasculature during development and ischemia. Investigative Ophthalmology and Visual Science 2011 52 12 8701 8710 10.1167/iovs.11-7870
187. Moussad E. E., Brigstock D. R., Connective tissue growth factor. What's in a name? Molecular Genetics and Metabolism 2000 71 1-2 276 292 10.1006/mgme.2000.3059
188. Kita T., Hata Y., Miura M., Kawahara S., Nakao S., Ishibashi T., Functional characteristics of connective tissue growth factor on vitreoretinal cells. Diabetes 2007 56 5 1421 1428 2-s2.0-34248152678 10.2337/db06-1644 (Pubitemid 46715616)
189. Kuiper E. J., van Nieuwenhoven F. A., de Smet M. D., van Meurs J. C., Tanck M. W., Oliver N., Klaassen I., van Noorden C. J. F., Goldschmeding R., Schlingemann R. O., The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy. PLoS ONE 2008 3 7 2-s2.0-50549089040 10.1371/journal.pone. 0002675 e2675
190. Fazel S. S., Chen L., Angoulvant D., Li S. H., Weisel R. D., Keating A., Li R. K., Activation of c-kit is necessary for mobilization of reparative bone marrow progenitor cells in response to cardiac injury. The FASEB Journal 2008 22 3 930 940 2-s2.0-40449105049 10.1096/fj.07-8636com (Pubitemid 351348144)
191. Huang P. H., Chen Y. H., Wang C. H., Chen J. S., Tsai H. Y., Lin F. Y., Lo W. Y., Wu T. C., Sata M., Chen J. W., Lin S. J., Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 8 1179 1184 2-s2.0-68149099660 10.1161/ATVBAHA.109. 189175
192. + stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation. American Journal of Physiology 2003 285 3 H931 H937 2-s2.0-0041358457 (Pubitemid 37048145)
193. Miyamoto Y., Suyama T., Yashita T., Akimaru H., Kurata H., Bone marrow subpopulations contain distinct types of endothelial progenitor cells and angiogenic cytokine-producing cells. Journal of Molecular and Cellular Cardiology 2007 43 5 627 635 2-s2.0-35448954459 10.1016/j.yjmcc.2007.08.001 (Pubitemid 47616261)
194. Dentelli P., Rosso A., Balsamo A., Benedetto S. C., Zeoli A., Pegoraro M., Camussi G., Pegoraro L., Brizzi M. F., C-KIT, by interacting with the membrane-bound ligand, recruits endothelial progenitor cells to inflamed endothelium. Blood 2007 109 10 4264 4271 2-s2.0-34248386939 10.1182/blood-2006- 06-029603 (Pubitemid 46743392)
195. Matsui J., Wakabayashi T., Asada M., Yoshimatsu K., Okada M., Stem cell factor/c-kit signaling promotes the survival, migration, and capillary tube formation of human umbilical vein endothelial cells. The Journal of Biological Chemistry 2004 279 18 18600 18607 2-s2.0-2442631556 10.1074/jbc.M311643200 (Pubitemid 38623281)
196. van Huyen J. P. D., Smadja D. M., Bruneval P., Gaussem P., Dal-Cortivo L., Julia P., Fiessinger J. N., Cavazzana-Calvo M., Aiach M., Emmerich J., Bone marrow-derived mononuclear cell therapy induces distal angiogenesis after local injection in critical leg ischemia. Modern Pathology 2008 21 7 837 846 2-s2.0-46049083232 10.1038/modpathol.2008.48 (Pubitemid 351896658)
197. Kelly D. J., Zhang Y., Gow R. M., Itescu S., Gilbert R. E., Cells expressing the stem cell factor receptor, c-kit, contribute to neoangiogenesis in diabetes. Diabetes and Vascular Disease Research 2005 2 2 76 80 2-s2.0-20444501445 (Pubitemid 40827000)
198. Bosch-Marce M., Okuyama H., Wesley J. B., Sarkar K., Kimura H., Liu Y. V., Zhang H., Strazza M., Rey S., Savino L., Zhou Y. F., McDonald K. R., Na Y., Vandiver S., Rabi A., Shaked Y., Kerbel R., LaVallee T., Semenza G. L., Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circulation Research 2007 101 12 1310 1318 2-s2.0-37349115260 10.1161/CIRCRESAHA.107.153346 (Pubitemid 350294648)
199. El-Asrar A. M. Abu., Struyf S., Opdenakker G., van Damme J., Geboes K., Expression of stem cell factor/c-kit signaling pathway components in diabetic fibrovascular epiretinal membranes. Molecular Vision 2010 16 1098 1107 2-s2.0-77955647882
200. Poulaki V., Joussen A. M., Mitsiades N., Mitsiades C. S., Iliaki E. F., Adamis A. P., Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy. American Journal of Pathology 2004 165 2 457 469 2-s2.0-3242758105 (Pubitemid 38971376)
201. Uthra S., Raman R., Mukesh B. N., Rajkumar S. A., Kumari P., Agarwal S., Paul P. G., Lakshmipathy P., Gnanamoorthy P., Sharma T., McCarty C. A., Kumaramanickavel G., Diabetic retinopathy and IGF-1 gene polymorphic cytosine-adenine repeats in a Southern Indian cohort. Ophthalmic Research 2007 39 5 294 299 2-s2.0-35048813608 10.1159/000108124 (Pubitemid 47557251)
202. Bikfalvi A., Han Z. C., Angiogenic factors are hematopoietic growth factors and vice versa. Leukemia 1994 8 3 523 529 2-s2.0-23444462259 (Pubitemid 24096713)
203. Krantz S. B., Erythropoietin. Blood 1991 77 3 419 434
204. Watanabe D., Suzuma K., Matsui S., Kurimoto M., Kiryu J., Kita M., Suzuma I., Ohashi H., Ojima T., Murakami T., Kobayashi T., Masuda S., Nagao M., Yoshimura N., Takagi H., Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. The New England Journal of Medicine 2005 353 8 782 792 2-s2.0-23944523376 10.1056/NEJMoa041773 (Pubitemid 41215487)
205. Takagi H., Watanabe D., Suzuma K., Kurimoto M., Suzuma I., Ohashi H., Ojima T., Murakami T., Novel role of erythropoietin in proliferative diabetic retinopathy. Diabetes Research and Clinical Practice 2007 77 3, supplement S62 S64 2-s2.0-34547676210 10.1016/j.diabres.2007.01.035 (Pubitemid 47212555)
206. Becerra S. P., Amaral J., Erythropoietin-an endogenous retinal survival factor. The New England Journal of Medicine 2002 347 24 1968 1970 10.1056/NEJMcibr022629 (Pubitemid 35429930)
207. Wilkinson-Berka J. L., Fletcher E. L., Angiotensin and bradykinin: targets for the treatment of vascular and neuro-glial pathology in diabetic retinopathy. Current Pharmaceutical Design 2004 10 27 3313 3330 2-s2.0-4644278153 10.2174/1381612043383179 (Pubitemid 39276619)
208. Kim J. H., Kim J. H., Yu Y. S., Cho C. S., Kim K. W., Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy. Journal of Cerebral Blood Flow and Metabolism 2009 29 3 621 628 2-s2.0-61349171233 10.1038/jcbfm.2008.154
209. Yamagishi S. I., Nakamura K., Imaizumi T., Advanced glycation end products (AGEs) and diabetic vascular complications. Current Diabetes Reviews 2005 1 1 93 106 2-s2.0-23644448608 10.2174/1573399052952631
210. Hughes J. M., Kuiper E. J., Klaassen I., Canning P., Stitt A. W., Van Bezu J., Schalkwijk C. G., van Noorden C. J. F., Schlingemann R. O., Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina. Diabetologia 2007 50 5 1089 1098 2-s2.0-34147117767 10.1007/s00125-007-0621-4 (Pubitemid 46559257)
211. Yamagishi S. I., Matsui T., Nakamura K., Inoue H., Takeuchi M., Ueda S., Fukami K., Okuda S., Imaizumi T., Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression. Microvascular Research 2008 75 1 130 134 10.1016/j.mvr.2007. 05.001 (Pubitemid 350266734)
212. Chmielewska K., Robaszkiewicz J., Kosatka M., Role of the retinal pigment epithelium (RPE) in the pathogenesis and treatment of diabetic macular edema (DME). Klinika Oczna 2008 110 7-9 318 320 2-s2.0-57849083146
213. Horiuchi K., Amizuka N., Takeshita S., Takamatsu H., Katsuura M., Ozawa H., Toyama Y., Bonewald L. F., Kudo A., Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor β Journal of Bone and Mineral Research 1999 14 7 1239 1249 2-s2.0-0032973197 10.1359/jbmr.1999.14.7.1239 (Pubitemid 29314070)
214. Yoshida S., Ishikawa K., Asato R., Arima M., Sassa Y., Yoshida A., Yoshikawa H., Narukawa K., Obika S., Ono J., Ohta S., Izuhara K., Kono T., Ishibashi T., Increased expression of periostin in vitreous and fibrovascular membranes obtained from patients with proliferative diabetic retinopathy. Investigative Ophthalmology and Visual Science 2011 52 8 5670 5678 10.1167/iovs.10-6625
215. Ishikawa K., Yoshida S., Kadota K., Nakamura T., Niiro H., Arakawa S., Yoshida A., Akashi K., Ishibashi T., Gene expression profile of hyperoxic and hypoxic retinas in a mouse model of oxygen-induced retinopathy. Investigative Ophthalmology and Visual Science 2010 51 8 4307 4319 2-s2.0-77955870163 10.1167/iovs.09-4605
216. Yoshida S., Yoshida A., Ishibashi T., Elner S. G., Elner V. M., Role of MCP-1 and MIP-1 α in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularization. Journal of Leukocyte Biology 2003 73 1 137 144 2-s2.0-0037241365 10.1189/jlb.0302117 (Pubitemid 36125684)
217. Tatemoto K., Hosoya M., Habata Y., Fujii R., Kakegawa T., Zou M. X., Kawamata Y., Fukusumi S., Hinuma S., Kitada C., Kurokawa T., Onda H., Fujino M., Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochemical and Biophysical Research Communications 1998 251 2 471 476 2-s2.0-0032552988 10.1006/bbrc.1998.9489 (Pubitemid 28505047)
218. Masri B., Knibiehler B., Audigier Y., Apelin signalling: a promising pathway from cloning to pharmacology. Cellular Signalling 2005 17 4 415 426 2-s2.0-10444230360 10.1016/j.cellsig.2004.09.018 (Pubitemid 39643060)
219. Devic E., Rizzoti K., Bodin S., Knibiehler B., Audigier Y., Amino acid sequence and embryonic expression of msr/apj, the mouse homolog of Xenopus X-msr and human APJ. Mechanisms of Development 1999 84 1-2 199 203 2-s2.0-0032811273 10.1016/S0925-4773(99)00081-7 (Pubitemid 29331675)
220. Kleinz M. J., Davenport A. P., Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells. Regulatory Peptides 2004 118 3 119 125 2-s2.0-1542300876 10.1016/j.regpep.2003.11.002 (Pubitemid 38296725)
221. Cox C. M., D'Agostino S. L., Miller M. K., Heimark R. L., Krieg P. A., Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Developmental Biology 2006 296 1 177 189 2-s2.0-33745947584 10.1016/j.ydbio.2006.04.452 (Pubitemid 44061763)
222. Qian J., Lu Q., Tao Y., Jiang Y. R., Vitreous and plasma concentrations of apelin and vascular endothelial growth factor after intravitreal bevacizumab in eyes with proliferative diabetic retinopathy. Retina 2011 31 1 161 168 2-s2.0-78651378252 10.1097/IAE.0b013e3181e46ad8
223. Ferrara N., Mass R. D., Campa C., Kim R., Targeting VEGF-A to treat cancer and age-related macular degeneration. Annual Review of Medicine 2007 58 491 504 2-s2.0-34047175559 10.1146/annurev.med.58.061705.145635 (Pubitemid 46706529)
224. Frystyk J., Tarnow L., Krarup Hansen T., Parving H. H., Flyvbjerg A., Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications. Diabetologia 2005 48 9 1911 1918 2-s2.0-24944545643 10.1007/s00125-005-1850-z (Pubitemid 41317848)
225. Mohan N., Monickaraj F., Balasubramanyam M., Rema M., Mohan V., Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy. Journal of Diabetes and Its Complications 2012 26 5 435 441 10.1016/j.jdiacomp. 2012.05.005
226. Mao D., Peng H., Li Q., Wang J., Li P., Hu K., Zhang X., Lei B., Aqueous humor and plasma adiponectin levels in proliferative diabetic retinopathy patients. Current Eye Research 2012 37 9 803 808 10.3109/02713683.2012.676700